MARKET

LSTA

LSTA

Lisata Therapeutics Inc
NASDAQ
3.860
-0.019
-0.50%
Closed 16:00 05/30 EDT
OPEN
3.810
PREV CLOSE
3.879
HIGH
3.870
LOW
3.810
VOLUME
4.95K
TURNOVER
13.65K
52 WEEK HIGH
9.75
52 WEEK LOW
2.360
MARKET CAP
30.78M
P/E (TTM)
-0.3493
1D
5D
1M
3M
1Y
5Y
HC Wainwright & Co. Reiterates Lisata Therapeutics (LSTA) Buy Recommendation
NASDAQ · 4d ago
H.C. Wainwright Keeps Their Buy Rating on Lisata Therapeutics (LSTA)
TipRanks · 5d ago
BRIEF-Lisata Therapeutics Announces Enhancements To Ongoing Phase 2B Ascend Trial Of LSTA1
Reuters · 6d ago
Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy
NASDAQ · 05/22 15:48
Analysts Are Bullish on These Healthcare Stocks: Lisata Therapeutics (LSTA), Adicet Bio (ACET)
TipRanks · 05/10 10:20
BRIEF-Lisata Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
Reuters · 05/09 21:59
Lisata Therapeutics Q1 EPS $(0.77) Beats $(0.81) Estimate
Benzinga · 05/09 20:47
Lisata Therapeutics GAAP EPS of -$0.77 beats by $0.04
Seeking Alpha · 05/09 20:30
More
About LSTA
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of therapies for the treatment of advanced solid tumors and other diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are not affected. LSTA1 also has the potential to modify the tumor microenvironment (TME). LSTA1 also has the potential to modify the tumor microenvironment. It is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors. In addition, it has clinical development programs based on its autologous CD34+ cell therapy technology platform.

Webull offers kinds of Lisata Therapeutics Inc stock information, including NASDAQ:LSTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LSTA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LSTA stock methods without spending real money on the virtual paper trading platform.